Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.
Five healthy volunteers and 18 patients with various degrees of renal impairment received 500 mg of meropenem intravenously as a 30-min infusion. Five dialysis patients were dosed 2 h prior to hemodialysis, and four of them were also dosed between hemodialysis treatments. Plasma and urine samples we...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1992
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191616/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510451/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.7.1532 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|